Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations
Blueprint Medicines Corporation
Blueprint Medicines Corporation
OHSU Knight Cancer Institute
Instituto Nacional de Cancerologia de Mexico
Massachusetts General Hospital
University of Pretoria
Dana-Farber Cancer Institute
Centre Hospitalier Intercommunal Creteil
Beth Israel Deaconess Medical Center
Norwegian Institute of Public Health
Amsterdam UMC, location VUmc
Hospices Civils de Lyon
Institut de Radioprotection et de Surete Nucleaire
Hospitales Universitarios Virgen del RocÃo
University of Chicago
H. Lee Moffitt Cancer Center and Research Institute
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
H. Lee Moffitt Cancer Center and Research Institute
University of Bern
Siemens Medical Solutions
Hospices Civils de Lyon
St. James's Hospital, Ireland
Tampere University
Slotervaart Hospital